CONMED Co. (NYSE:CNMD) Given Average Recommendation of “Moderate Buy” by Analysts
CONMED Co. (NYSE:CNMD – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among […]
More Stories
Leerink Partnrs Brokers Lift Earnings Estimates for KPTI
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Research analysts at Leerink Partnrs upped their Q3 2025 EPS estimates for...
Sidoti Csr Issues Pessimistic Outlook for FET Earnings
Forum Energy Technologies, Inc. (NYSE:FET – Free Report) – Sidoti Csr reduced their Q3 2025 earnings per share (EPS) estimates...
CIBC Issues Positive Forecast for Nexus Industrial REIT (TSE:NXR.UN) Stock Price
Nexus Industrial REIT (TSE:NXR.UN – Get Free Report) had its price target lifted by analysts at CIBC from C$7.50 to...
Q3 Earnings Estimate for Immunocore Issued By HC Wainwright
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) – Investment analysts at HC Wainwright increased their Q3 2025 EPS...
Roth Capital Estimates Gaia’s Q3 Earnings (NASDAQ:GAIA)
Gaia, Inc. (NASDAQ:GAIA – Free Report) – Equities researchers at Roth Capital cut their Q3 2025 earnings per share (EPS)...
HC Wainwright Expects Increased Earnings for Exodus Movement
Exodus Movement, Inc. (NYSEAMERICAN:EXOD – Free Report) – Stock analysts at HC Wainwright increased their Q3 2025 earnings per share...